PAR General discussion, page-107

First 107 Last

Share
Profile

Follow
Beaza79

5,112 Posts.

662

17/12/21

08:56

Post #: 58355952
Share

Originally posted by MisterMister: ↑

i think its safe enough, i do have issues with the efficacy (i wont go into it again, look at many of my past posts) but yes i think it likely has some benefit, commercialisation i think is its weakest factor though with the weak IP and its delivery mechanism which doesnt allow for self administration. people thinking this is like $2k per treatment - thats for the drug... add in physician costs for 12+ visits particularly in the US and its likely multiples from there. doesn't end up being a cheap treatment at all. i know people have said it could be like the insulin self injectible.... can it? and who says so? My main point is that even if it does commercialise - i just dont zee it having anywhere near the market penetration that some people spruik on here like its curing cancer. Potentially a bit more if DMOAD but until its paired with MRI data its meaningless. Biomarkers mean absolutely nothing unless you're seeing structural changes which is also why i think the 008 study is a bit of a sham. People have been fed this line that biomarkers will prove DMOAD and thats just a lie. It would help support MRI data, but the FDA will piss themselves laughing if thats all you came with. some things just havent smelled right for a while which is why i got out in the first place and now the perception avross the investor base (at least a lot more than the hearts would like) is that things almost seem like "if its bad, don't say anything" is happening all over the shop. wait and see, but thats where my head is at.

Expand

That’s all fair enough. Are u going to buy back in at any stage?

PAR Price at posting: $1.91 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SRI

From the Floor: Sipa in the field, as search for gold & base metals continues in WA

RTR

Rumble happens upon high-grade tungsten find in WA, with grades beyond 18%

From the Floor with Kim Beazley at Diggers and Dealers 2024

PV1

Provaris pushes on with hydrogen alongside Nordic partner inking deal for German supply by sea

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

There are more pages in this discussion • 233 more messages in this thread...

First 107 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $80.45M

Open	High	Low	Value	Volume
23.0¢	23.5¢	23.0¢	$26.71K	116.0K

Buyers (Bids)

No.	Vol.	Price($)
3	52687	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	3305	3

View Market Depth

No.	Vol.	Price($)
2	2687	0.230
3	76670	0.225
8	196769	0.220
4	62690	0.215
6	72358	0.210

Price($)	Vol.	No.
0.235	3305	3
0.240	12941	3
0.250	47036	4
0.260	9393	4
0.265	51198	2

Last trade - 10.41am 06/08/2024 (20 minute delay)

PAR (ASX) Chart

PAR General discussion, page-107

From the Floor: Sipa in the field, as search for gold & base metals continues in WA

Rumble happens upon high-grade tungsten find in WA, with grades beyond 18%

From the Floor with Kim Beazley at Diggers and Dealers 2024

Provaris pushes on with hydrogen alongside Nordic partner inking deal for German supply by sea

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PAR General discussion, page-107

Top Stories

From the Floor: Sipa in the field, as search for gold & base metals continues in WA

Rumble happens upon high-grade tungsten find in WA, with grades beyond 18%

From the Floor with Kim Beazley at Diggers and Dealers 2024

Provaris pushes on with hydrogen alongside Nordic partner inking deal for German supply by sea

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News